LOS ANGELES, Feb. 25, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Pinterest, Inc. (“Pinterest” or “the Company”) (NYSE: PINS) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Pinterest reported its Q4 2025 financial results on February 12, 2026. The Co ...

LOS ANGELES--(BUSINESS WIRE)--The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Novo Nordisk A/S ("Novo Nordisk†or "the Company†) (NYSE: NVO) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Novo Nordisk is the subject of a report by CNBC published on February 23, 2026, titled: "N ...

Core Viewpoint - Johnson Fistel, PLLP is investigating whether Snowflake Inc. and its executives complied with federal securities laws following significant investor losses after the company's recent financial disclosures [1][5]. Group 1: Investigation Details - The investigation is focused on potential recovery of losses incurred by investors who purchased Snowflake securities [2][5]. - The investigation was prompted by Snowflake's financial results announcement on February 28, 2024, which included changes in customer behavior and product-related developments that negatively impacted the company's outlook [3]. Group 2: Stock Price Impact - Following the financial disclosures, Snowflake's stock price dropped sharply from approximately $230.00 per share to $188.28 per share on February 29, 2024, marking a decline of $41.72 per share, or over 18% [4]. Group 3: Johnson Fistel's Background - Johnson Fistel, PLLP is a nationally recognized law firm specializing in shareholder rights and securities class action lawsuits, with a strong track record of recovering funds for investors [6][7].

Core Viewpoint - The Schall Law Firm is investigating Newegg Commerce, Inc. for potential violations of securities laws following the detention of its chairman, which led to a significant drop in share price [1][2]. Group 1: Investigation Details - The investigation focuses on whether Newegg issued false or misleading statements and failed to disclose important information to investors [2]. - Newegg's chairman and controlling shareholder, He Zhitao, was detained and placed under investigation, which was disclosed on January 21, 2026 [2]. Group 2: Market Reaction - Following the news of the chairman's detention, Newegg's shares fell by 17.7% on the same day [2].

Core View of the Article - The Schall Law Firm is investigating claims against CoreWeave, Inc. for potential violations of securities laws related to misleading statements and undisclosed information affecting investors [1][2]. Financial Performance - CoreWeave announced its Q3 2025 financial results on November 10, 2025, revealing a reduction in capital expenditure forecasts and a lowered full-year 2025 revenue forecast due to capacity limitations [2]. - Following the announcement, shares of CoreWeave experienced a significant decline, falling by more than 16.3% the next day [2].

Core Viewpoint - The Schall Law Firm is investigating potential securities law violations by Insmed Incorporated following the announcement of disappointing clinical trial results for its drug brensocatib, which led to a significant drop in the company's stock price [1][2]. Group 1: Investigation Details - The investigation is centered on whether Insmed made false or misleading statements or failed to disclose important information to investors [2]. - Insmed's Phase 2b BiRCh study for brensocatib in chronic rhinosinusitis without nasal polyps did not meet its primary or secondary efficacy endpoints, resulting in the decision to discontinue the drug's development [2]. Group 2: Market Reaction - Following the announcement of the trial results, Insmed's shares experienced a decline of nearly 16.1% the next day [2].

Core Viewpoint - The Schall Law Firm is investigating Anavex Life Sciences Corp for potential violations of securities laws following a significant drop in share price after a negative trend vote on its Marketing Authorisation Application for blarcamesine [1] Group 1: Investigation Details - The investigation focuses on whether Anavex issued false or misleading statements or failed to disclose important information to investors [1] - Anavex announced on November 14, 2025, that it received a negative trend vote from the Committee for Medicinal Products for Human Use (CHMP) regarding its Marketing Authorisation Application for blarcamesine [1] Group 2: Market Reaction - Following the announcement of the negative trend vote, shares of Anavex fell by more than 35.9% on the same day [1]

Core Viewpoint - The Schall Law Firm is investigating claims against Alaska Air Group, Inc. for potential violations of securities laws related to misleading statements and undisclosed information impacting investors [1] Group 1: Investigation Details - The investigation focuses on whether Alaska Air issued false or misleading statements or failed to disclose relevant information to investors [1] - On October 23, 2025, Alaska Air announced an IT outage that caused a systemwide ground stop for Alaska and Horizon Air flights, leading to significant delays and cancellations [1] Group 2: Market Reaction - Following the announcement of the IT outage, shares of Alaska Air fell by more than 6.1% the next day [1]

Core Viewpoint - Johnson Fistel, PLLP has initiated an investigation into potential breaches of fiduciary duties by the board members of Sealed Air Corporation regarding the proposed acquisition by CD&R, which is perceived to undervalue the company’s shares [1][2]. Group 1: Company Overview - Sealed Air Corporation has entered into a definitive merger agreement with CD&R, where CD&R will acquire all outstanding shares of Sealed Air common stock for $42.15 per share in cash [2]. Group 2: Legal Firm Background - Johnson Fistel, PLLP is a nationally recognized shareholder-rights law firm with multiple offices across the United States, representing both individual and institutional investors in securities class action lawsuits [3]. Group 3: Achievements of the Law Firm - In 2024, Johnson Fistel was ranked among the Top 10 Plaintiff Law Firms by ISS Securities Class Action Services, having recovered approximately $90.725 million for clients in cases where it served as lead or co-lead counsel [4].

Core Viewpoint - The Schall Law Firm is investigating Exelixis, Inc. for potential violations of securities laws related to misleading statements and undisclosed information affecting investors [1][2]. Group 1: Investigation Details - The investigation centers on whether Exelixis issued false or misleading statements and failed to disclose critical information to investors [2]. - Exelixis reported Q2 2025 financial results on July 28, 2025, indicating product revenue for cabozantinib was below expectations [2]. - The company decided not to proceed to the phase 3 portion of the STELLAR-305 study due to emerging competition and assessment of other commercial opportunities [2]. Group 2: Market Reaction - Following the announcement regarding the phase 3 trial decision, Exelixis shares fell by almost 16.8% the next day [2].